Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
375 | 3497 | 42.7 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPATOCYTE GROWTH FACTOR | Author keyword | 497 | 47% | 22% | 784 |
2 | C MET | Author keyword | 427 | 56% | 15% | 518 |
3 | HGF | Author keyword | 157 | 40% | 9% | 304 |
4 | SCATTER FACTOR | Author keyword | 112 | 68% | 3% | 98 |
5 | NK4 | Author keyword | 96 | 88% | 1% | 45 |
6 | MET | Author keyword | 87 | 33% | 6% | 221 |
7 | C MET INHIBITOR | Author keyword | 81 | 96% | 1% | 25 |
8 | HGF SF | Author keyword | 66 | 65% | 2% | 62 |
9 | HEPATOCYTE GROWTH FACTOR HGF | Author keyword | 50 | 48% | 2% | 75 |
10 | MOL REGENERAT MED | Address | 46 | 40% | 3% | 90 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPATOCYTE GROWTH FACTOR | 497 | 47% | 22% | 784 | Search HEPATOCYTE+GROWTH+FACTOR | Search HEPATOCYTE+GROWTH+FACTOR |
2 | C MET | 427 | 56% | 15% | 518 | Search C+MET | Search C+MET |
3 | HGF | 157 | 40% | 9% | 304 | Search HGF | Search HGF |
4 | SCATTER FACTOR | 112 | 68% | 3% | 98 | Search SCATTER+FACTOR | Search SCATTER+FACTOR |
5 | NK4 | 96 | 88% | 1% | 45 | Search NK4 | Search NK4 |
6 | MET | 87 | 33% | 6% | 221 | Search MET | Search MET |
7 | C MET INHIBITOR | 81 | 96% | 1% | 25 | Search C+MET+INHIBITOR | Search C+MET+INHIBITOR |
8 | HGF SF | 66 | 65% | 2% | 62 | Search HGF+SF | Search HGF+SF |
9 | HEPATOCYTE GROWTH FACTOR HGF | 50 | 48% | 2% | 75 | Search HEPATOCYTE+GROWTH+FACTOR+HGF | Search HEPATOCYTE+GROWTH+FACTOR+HGF |
10 | HEPATOCYTE GROWTH FACTOR SCATTER FACTOR | 42 | 62% | 1% | 43 | Search HEPATOCYTE+GROWTH+FACTOR+SCATTER+FACTOR | Search HEPATOCYTE+GROWTH+FACTOR+SCATTER+FACTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACTOR SCATTER FACTOR | 804 | 60% | 25% | 877 |
2 | C MET | 572 | 45% | 28% | 966 |
3 | SCATTER FACTOR | 508 | 53% | 19% | 668 |
4 | HEPATOPOIETIN A | 222 | 80% | 4% | 136 |
5 | HGF RECEPTOR | 218 | 78% | 4% | 142 |
6 | HEPATOCYTE GROWTH FACTOR | 212 | 20% | 27% | 946 |
7 | MET HGF RECEPTOR | 143 | 70% | 3% | 118 |
8 | FACTOR HGF | 143 | 69% | 3% | 122 |
9 | HGF | 119 | 55% | 4% | 148 |
10 | PAPILLARY RENAL CARCINOMAS | 87 | 74% | 2% | 65 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Targeting MET in cancer: rationale and progress | 2012 | 354 | 174 | 65% |
Met, metastasis, motility and more | 2003 | 1326 | 104 | 67% |
Drug development of MET inhibitors: targeting oncogene addiction and expedience | 2008 | 352 | 124 | 76% |
MET signalling: principles and functions in development, organ regeneration and cancer | 2010 | 306 | 162 | 56% |
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention | 2005 | 280 | 206 | 87% |
The emerging role of MET/HGF inhibitors in oncology | 2013 | 45 | 94 | 87% |
Scatter-factor and semaphorin receptors: Cell signalling for invasive growth | 2002 | 430 | 147 | 63% |
MET: a promising anticancer therapeutic target | 2012 | 85 | 133 | 77% |
Hepatocyte growth factor twenty years on: Much more than a growth factor | 2011 | 102 | 72 | 83% |
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors | 2014 | 13 | 111 | 75% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL REGENERAT MED | 46 | 40% | 2.6% | 90 |
2 | COURSE ADV MED | 44 | 58% | 1.4% | 50 |
3 | KRINGLE PHARMA JOINT REGENERAT DRUG DISCO | 34 | 70% | 0.8% | 28 |
4 | TUMOR DYNAM REGULAT | 17 | 44% | 0.8% | 29 |
5 | BIOCHEMBIOMED | 17 | 100% | 0.2% | 8 |
6 | ONCOL BIOCHEM | 15 | 45% | 0.7% | 25 |
7 | ONCOLBIOMED | 6 | 71% | 0.1% | 5 |
8 | IRCC | 6 | 23% | 0.6% | 22 |
9 | CANC TREATMENT IRCC | 5 | 22% | 0.6% | 20 |
10 | EXPT CLIN MOL ONCOL | 5 | 63% | 0.1% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000216901 | RON RECEPTOR//HEPATOCYTE GROWTH FACTOR LIKE PROTEIN//RON |
2 | 0.0000127401 | MACC1//METASTASIS ASSOCIATED IN COLON CANCER 1//MACC 1 |
3 | 0.0000086025 | MATRIPTASE//HAI 1//HEPSIN |
4 | 0.0000058364 | S 1 2 DICARBOXYETHYLGLUTATHIONE//ALPHA2 ADRENERGIC RESPONSE//BIOCHEM PHARMACOL GRP |
5 | 0.0000056675 | LIVER REGENERATION//RAT GENOME 230 20 ARRAY//PARTIAL HEPATECTOMY |
6 | 0.0000039156 | KERATINOCYTE GROWTH FACTOR//KGF//KERATINOCYTE GROWTH FACTOR RECEPTOR |
7 | 0.0000037596 | EPIMORPHIN//MORPHOREGULAT//VERTEBROGENESIS |
8 | 0.0000037170 | AUGMENTER OF LIVER REGENERATION//HEPATIC STIMULATOR SUBSTANCE//SULFHYDRYL OXIDASE |
9 | 0.0000037104 | CRIZOTINIB//ANAPLASTIC LYMPHOMA KINASE//ALK |
10 | 0.0000031108 | AUTOCRINE MOTILITY FACTOR//AUTOCRINE MOTILITY FACTOR RECEPTOR//PHOSPHOGLUCOSE ISOMERASE |